Fei Lin
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Ferroptosis and cancer prognosis
- Renal cell carcinoma treatment
Papers in
-
- Circular RNAs in diseases 3
- Ubiquitin and proteasome pathways 2
- Epigenetics and DNA Methylation 2
- Surgery 6
- Adrenal and Paraganglionic Tumors 3
- Bladder and Urothelial Cancer Treatments 2
- Co-authors
- Yong Wei (20 shared papers)Zhi‐Bin Ke (22 shared papers)Ning Xu (22 shared papers)Xue‐Yi Xue (22 shared papers)Yu‐Peng Wu (12 shared papers)Qing‐Shui Zheng (20 shared papers)Shao‐Hao Chen (15 shared papers)Ye‐Hui Chen (7 shared papers)
- Journals
- Cell Death and Disease (3 papers)Aging (2 papers)Ecotoxicology and Environmental Safety (2 papers)Environmental Pollution (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Fei Lin
33 papers receiving 302 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 79
- Pulmonary and Respiratory Medicine 67
- Molecular Biology 125
- Health, Toxicology and Mutagenesis 18
- Genetics 12
Countries citing papers authored by Fei Lin
This map shows the geographic impact of Fei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Lin more than expected).
Fields of papers citing papers by Fei Lin
This network shows the impact of papers produced by Fei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Lin. The network helps show where Fei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 34 | |
| 2 | 2004 | 25 | |
| 3 | 2022 | 22 | |
| 4 | 2021 | 20 | |
| 5 | 2020 | 20 | |
| 6 | 2017 | 19 | |
| 7 | SHMT2 promotes tumor growth through VEGF and MAPK signaling pathway in breast cancer. | 2022 | 18 |
| 8 | 2020 | 14 | |
| 9 | 2020 | 14 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 10 | |
| 12 | 2024 | 10 | |
| 13 | 2020 | 10 | |
| 14 | 2021 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2024 | 6 | |
| 20 | 2023 | 5 |
About Fei Lin
Fei Lin is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Health, Toxicology and Mutagenesis, having authored 34 papers that have together received 306 indexed citations. Recurring topics across this work include Circular RNAs in diseases (3 papers), Adrenal and Paraganglionic Tumors (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Renal cell carcinoma treatment (2 papers), Ubiquitin and proteasome pathways (2 papers), Influenza Virus Research Studies (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (79 citations), Pulmonary and Respiratory Medicine (67 citations), Molecular Biology (125 citations), Health, Toxicology and Mutagenesis (18 citations) and Genetics (12 citations). Fei Lin has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yong Wei, Zhi‐Bin Ke, Ning Xu, Xue‐Yi Xue, Yu‐Peng Wu, Qing‐Shui Zheng, Shao‐Hao Chen, Ye‐Hui Chen, Xiaodan Lin and M. Mónica Giusti. Their work appears in journals such as Cell Death and Disease, Aging, Ecotoxicology and Environmental Safety, Environmental Pollution and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.